NumberOfSamples: n=80  
Disease: Alzheimer’s disease  
Disease: Parkinson’s disease  
AssayName: Tandem Mass Tag (TMT) isobaric labeling  
AssayName: synchronous precursor selection-based MS3 (SPS-MS3) mass spectrometry  
AssayName: TMT 10-plex assay  
PooledSample: global internal standard (GIS)  
CleavageAgent: Lysyl endopeptidase (Wako)  
CleavageAgent: Trypsin (Promega)  
ReductionReagent: 1 mM dithiothreitol (DTT)  
AlkylationReagent: 5 mM iodoacetamide (IAA)  
Compound: 8 M urea  
Compound: HALT protease and phosphatase inhibitor cocktail (ThermoFisher)  
Instrument: Bullet Blender (NextAdvance)  
Instrument: Agilent 1100 HPLC system  
Instrument: Orbitrap Fusion mass spectrometer  
Instrument: Dionex RSLCnano UPLC  
FractionationMethod: Electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) fractionation  
Separation: C18 Sep-Pak column (Waters)  
PrecursorMassTolerance: 20 ppm  
FragmentMassTolerance: 0.6 daltons  
NumberOfMissedCleavages: two  
Modification: TMT tags on lysine residues and peptide N-termini (+ 229.162932 Da)  
Modification: carbamidomethylation of cysteine residues (+ 57.02146 Da)  
Modification: oxidation of methionine residues (+ 15.99492 Da)  
Modification: deamidation of asparagine and glutamine (+0.984 Da)  
GradientTime: 45 min  
GradientTime: 105 min  
FlowRateChromatogram: 300 nl  
FragmentationMethod: collision-induced dissociation (CID)-MS2 fragmentation  
FragmentationMethod: higher-energy collision dissociation (HCD) fragmentation  
CollisionEnergy: 35%  
CollisionEnergy: 65%  
MS2MassAnalyzer: linear ion trap  
TechnicalReplicate: fraction 19